Else Nutrition Holdings

Else Nutrition released results for the quarter ended 30.06.2026: loss per share amounted to 0.15 CAD (prior-year quarter: -4,000 CAD). Revenue fell 32.0 percent to 1.0 million CAD from 1.5 million CAD in the prior-year period. » Mere på finanzen.net

Else Nutrition reported Q3 2025 revenue of $1.66m (prior year $1.79m), an improved gross margin of 34% versus -9% a year earlier, and a 68% reduction in operating expenses to $1.15m. Monthly cash burn was reduced to below $200,000; the company is targeting cash-flow breakeven by late 2026 to early 2027. Else continues to focus on product innovation in plant‑based infant nutrition, expanding its U.S. presence, ongoing clinical studies, and has completed a 10:1 share consolidation. » Mere på de.investing.com

Else Nutrition released numbers for the quarter ended 30.09.2025 with earnings per share (EPS) of -0.02 CAD compared with -0.700 CAD a year earlier. Revenue fell 7.26 percent to 1.7 million CAD (prior year: 1.8 million CAD). » Mere på finanzen.net

Else Nutrition reported a revenue decline in Q2 2025 to $1.5 million from $2.6 million a year earlier, improved its net loss to $1.4 million (−43%), and cut operating expenses by almost 60%. The company is pursuing operational restructuring, expanding its online business, pushing international expansion and evaluating new product categories and partnerships. Ready-to-drink children’s shakes are now available in Walmart stores, but the launch of an adult product line was delayed due to cash-flow constraints. Else Nutrition aims to reach cash-flow break-even in late 2026 to early 2027. » Mere på de.investing.com